OBJECTIVES: To evaluate a turbidimetric immunoassay for the measurement of ferritin, and to assay this method in a group of patients undergoing an autologous blood transfusion program. DESIGN AND METHODS: We used an ILab 900 analyzer. This instrument automates a particle-enhanced immunoturbidimetric assay with an analysis time of 9 min. This technique was compared with a microparticle immunoassay. The turbidimetric assay was used to measure ferritin in a group of 30 patients undergoing an autologous blood transfusion program. RESULTS: The assay was linear in the range 3-1400 microg/L (r = 0.9999). The intra- and inter-assay imprecision (CV) at 20, 97 and 469 microg/L were <3.0 and <5.0%, respectively. Recovery was 88. 7 to 97.4%. The detection limit was 3 microg/L. Hemoglobin (</=4 g/L), mild hyperbilirubilinemia (bilirubin </=50 micromol/L), triglycerides (</=10 mmol/L) and myeloma paraproteins did not interfere with the assay. The assay showed good correlation with a microparticle enzymoimmunoassay (r = 0.994) with a mean difference between methods of -6 +/- 16 microg/L. This method was sensitive, accurate, and fast enough for an efficient follow-up of autologous blood transfusion patients. CONCLUSIONS: The new automated serum assay for ferritin is an attractive alternative that avoids the need for dedicated instrumentation.
OBJECTIVES: To evaluate a turbidimetric immunoassay for the measurement of ferritin, and to assay this method in a group of patients undergoing an autologous blood transfusion program. DESIGN AND METHODS: We used an ILab 900 analyzer. This instrument automates a particle-enhanced immunoturbidimetric assay with an analysis time of 9 min. This technique was compared with a microparticle immunoassay. The turbidimetric assay was used to measure ferritin in a group of 30 patients undergoing an autologous blood transfusion program. RESULTS: The assay was linear in the range 3-1400 microg/L (r = 0.9999). The intra- and inter-assay imprecision (CV) at 20, 97 and 469 microg/L were <3.0 and <5.0%, respectively. Recovery was 88. 7 to 97.4%. The detection limit was 3 microg/L. Hemoglobin (</=4 g/L), mild hyperbilirubilinemia (bilirubin </=50 micromol/L), triglycerides (</=10 mmol/L) and myeloma paraproteins did not interfere with the assay. The assay showed good correlation with a microparticle enzymoimmunoassay (r = 0.994) with a mean difference between methods of -6 +/- 16 microg/L. This method was sensitive, accurate, and fast enough for an efficient follow-up of autologous blood transfusion patients. CONCLUSIONS: The new automated serum assay for ferritin is an attractive alternative that avoids the need for dedicated instrumentation.
Authors: Lotfi S Bin Dahman; Khalid M Sumaily; Essa M Sabi; Mohammed A Hassan; Abeer M Bin Thalab; Asrar S Sayad; Saleh M Bin Kolaib; Fatima M Alhadhrmi Journal: Diagnostics (Basel) Date: 2022-01-27
Authors: Maria N Garcia-Casal; Juan P Peña-Rosas; Eloisa Urrechaga; Jesus F Escanero; Junsheng Huo; Ricardo X Martinez; Lucero Lopez-Perez Journal: PLoS One Date: 2018-05-03 Impact factor: 3.240